**Core tip:** Hepatic myelolipoma is extremely rare. To date, only 10 cases have been reported in the English-language medical literature. In the present study, we report the first case of the synchronous occurrence of a hepatic myelolipoma and two hepatocellular carcinomas in different liver sections of one patient, who received a right hepatectomy, a left hepatic lobectomy, and a cholecystectomy. We also highlight the diagnosis and treatment of a hepatic myelolipoma and conduct a literature review to deepen the understanding of the subject.

INTRODUCTION
============

Myelolipoma is a rare benign tumor composed of fat and bone marrow components. The adrenal gland is the most common location\[[@B1],[@B2]\]. Myelolipoma in the liver is extremely rare. To our knowledge, 10 cases have been reported in the English-language medical literature as individual case reports\[[@B3]-[@B12]\]. In one of the cases, the hepatic myelolipoma was found within a hepatocellular carcinoma (HCC)\[[@B6]\]. Hepatic myelolipomas are usually incidentally discovered by ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), or autopsy examination. The first case of hepatic myelolipoma was reported in France by Grosdidier et al\[[@B13]\] in 1973, and it was found on a plain abdominal X-ray during a regular checkup for diabetes and obesity. Although hepatic imaging modalities will lead to detection of the tumor, the diagnosis of a hepatic myelolipoma has to be confirmed by a histopathologic examination of the resected specimen. In the present study, we present the eleventh case of hepatic myelolipoma to be reported in the English-language medical literature. This is also the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient. The clinical, imaging, and pathologic features of this case are described, and the subject of hepatic myelolipoma is briefly reviewed to deepen our understanding of it.

CASE REPORT
===========

On November 28, 2014, a 26-year-old female was admitted to our hospital because of a 4-d history of upper abdominal pain. Her abdomen was soft, lax, and non-distended, with no palpable mass. The patient had no history of hepatitis B virus infection, hepatitis C virus infection or non-alcoholic fatty liver disease (NAFLD). Her family history was not significant. Abnormal laboratory results including alpha fetoprotein (AFP), 7529.2 ng/mL (normal, 20); carbohydrate antigen 125, 99.4 U/mL (normal, 0-35); serum creatinine, 42 μmol/L (normal, 45-84); serum sodium, 131 mmol/L (normal, 136-145); glutamyl transpeptidase, 103 U/L (normal, 7-32); fibrinogen, 4.45 g/L (normal, 2.00-4.00); and D-2-dimer, 9611 μg/L (normal, 0-700). The unenhanced CT images showed a well-defined low-density mass with adipose components in the right liver lobe, 4.2 cm × 4.1 cm in size (Figure [1A](#F1){ref-type="fig"}). Two inhomogeneous low-density masses were found in the left liver lobe, 8.6 cm × 7.7 cm and 2.6 cm × 2.6 cm in size (Figure [1B](#F1){ref-type="fig"} and C). In the contrast-enhanced CT images, the masses in both the right and the left liver lobe were heterogeneously enhanced (Figure [1D](#F1){ref-type="fig"}-F). Based on the results of the imaging examination, the mass in the right liver lobe was preliminarily considered to be a hamartoma, and the two masses in the left liver lobe were preliminarily considered to be HCCs.

![Computed tomography findings. A: An unenhanced computed tomography (CT) image showing a well-defined low-density mass (arrow) with adipose components in the right liver lobe, 4.2 cm × 4.1 cm in size; B and C: Two inhomogeneous low-density masses (arrows) are shown in the left liver lobe, 8.6 cm × 7.7 cm and 2.6 cm × 2.6 cm in size, respectively; D, E and F: In the contrast-enhanced CT image, the masses in both the right and left liver lobes are heterogeneously enhanced.](WJG-22-9654-g001){#F1}

After sufficient pre-operative preparation, a laparotomy was performed. One mass was found in the V section of the right liver lobe, and two masses were found in the left liver lobe, reflecting what was seen in the CT scan. We completed a right hepatectomy and a left hepatic lobectomy. Because the gallbladder was close to the tumor, a cholecystectomy was also performed. The intraoperative frozen pathology revealed that the tumor in the right liver lobe was a hepatic myelolipoma, and that the two tumors in the left liver lobe were HCCs.

Macroscopically, the mass in the right liver lobe had a solid capsule that was 5.0 cm × 4.0 cm. The two masses in the left liver lobe were solid and were 9.5 cm × 6.5 cm × 5 cm and 3.2 cm × 2.0 cm in size, respectively. Microscopically, the tumor in the right liver lobe consisted of adipose tissue and hematopoietic elements containing erythroid tissue, megakaryocytes and myeloid colonies, consistent with a myelolipoma (Figure [2A](#F2){ref-type="fig"} and B). Tumor cells in the left liver lobe were in a funicular arrangement and showed invasive growth with significant atypia, compatible with malignant hepatic cancers (Figure [2C](#F2){ref-type="fig"} and D). Immunohistochemical investigation showed that hepatocyte and CD34 proteins were positive in the tumors of the left liver lobe (Figure [3](#F3){ref-type="fig"}), while AFP, GPC-3, HMB45, Melan-A and SMA were negative. Finally, the tumor in the right liver lobe was diagnosed as a hepatic myelolipoma, and the tumors in the left liver lobe were diagnosed as HCCs. After surgery, the patient developed an intra-abdominal infection and was hospitalized for 27 d. Unfortunately, two months later, a CT scan of the liver suggested the recurrence of the HCC. The patient received four transcatheter arterial chemoembolization (TACE) procedures and one iodine 131I metuximab injection in our hospital. However, the HCC metastasized to the lung eight months after surgery. The patient was then lost after nine months of follow-up.

![Microscopic examination. A and B: The tumor (red arrow) in the right liver lobe consists of adipose tissue and hematopoietic elements containing erythroid tissue, megakaryocytes and myeloid colonies, consistent with a myelolipoma (A: HE, 100 ×; B: HE, 400 ×); C and D: The tumor cells (black arrow) in the left liver lobe are in a funicular arrangement and are growing invasively with significant atypia, compatible with a malignant hepatic cancer (C: HE, 100 ×; D: HE, 400 ×). The areas marked by green arrows are normal liver tissue. HE: Hematoxylin and eosin.](WJG-22-9654-g002){#F2}

![Immunohistochemical investigation. Hepatocyte (A) and CD34 (B) proteins were positive in the tumors of the left liver lobe (100 ×).](WJG-22-9654-g003){#F3}

DISCUSSION
==========

Myelolipoma is a rare type of benign, nonfunctioning tumor of mesenchymal origin, which is composed of various proportions of fat and hematopoietic cells\[[@B14]\]. As such, it resembles a site of extramedullary hematopoiesis. The adrenal gland is the most common site of myelolipomas; autopsy series have revealed the prevalence of myelolipomas in the adrenal gland at autopsy to be 0.08%-0.8%\[[@B2],[@B15],[@B16]\]. Extraadrenal myelolipomas are very rare\[[@B17]\]. They have been reported in the parietal pleura\[[@B18]\], presacral area\[[@B19]\], intrathoracic paravertebral area\[[@B20]\], mediastinum\[[@B21],[@B22]\], gastric antrum\[[@B23]\], perirenal tissue\[[@B24]\], and right iliac fossa\[[@B25]\]. To date, only ten cases of hepatic myelolipomas have been reported in the English-language medical literature\[[@B3]-[@B12]\] (Table [1](#T1){ref-type="table"}). In one of these cases, the hepatic myelolipoma was found in a HCC\[[@B6]\]. In the present study, we report the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient. Table [2](#T2){ref-type="table"} summarizes the clinical data from all 11 cases of hepatic myelolipoma reported in the English-language medical literature, including the present study. Continuous variables were summarized as the mean ± the standard deviation (SD) and the range. Statistical analyses were conducted using SPSS version 20.0 for Windows (SPSS Inc., Chicago, IL, United States). The mean age of these patients was 51.45 ± 16.74 years (range 25-76 years) and the male-female ratio was 5:6. Forty percent of patients were asymptomatic; most patients were symptomatic. The right liver lobe was the reported site of the myelolipoma in nine (81.82%) of the patients; the left liver lobe was the reported site in 2 patients. The mean tumor size was 6.69 ± 4.71 cm (range 1.4-15 cm). Seven patients (63.64%) underwent tumor resection.

###### 

Summary of clinical data on patients with hepatic myelolipoma in the English literature

  **Ref**.                     **Year**   **Sex/age**   **Symptom**                                     **location**                      **Imaging method**              **Number**   **Size (cm)**   **Treatment**
  ---------------------------- ---------- ------------- ----------------------------------------------- --------------------------------- ------------------------------- ------------ --------------- -------------------------------
  Present case                 2016       F/26          Upper abdomen pain                              Right liver lobe                  CT                              Solitary     5.0             Resection
  Menozzi et al\[[@B3]\]       2016       F/72          Asymptomatic                                    Right liver lobe                  US, CT, CEUS                    Solitary     3.5             NA
  Radhi\[[@B4]\]               2010       M/76          Symptoms related to a urinary tract infection   Segment VIII of the right liver   US, CT                          Solitary     3.2             NA
  Savoye-Coll et al\[[@B5]\]   2000       M/25          Asymptomatic                                    Segment IV                        MRI                             Solitary     9.0             Left hepatectomy
  Van et al\[[@B6]\]           1994       M/57          Asymptomatic                                    Right liver lobe                  US, CT                          Solitary     1.4             Hemihepatectomy
  Moreno et al\[[@B7]\]        1991       M/40          Malaise, anorexia, fever                        Right liver lobe                  X-rays, CT, Radioisotope scan   Solitary     15.0            Right hepatic lobectomy
  Nishizaki et al\[[@B8]\]     1989       F/56          Right upper abdominal pain                      Right post segment                US; CT, Hepatic arteriography   Solitary     5.5             Right posterior segmentectomy
  subcapsule                                                                                                                                                                                           
  Kaurich et al\[[@B9]\]       1988       F/42          Asymptomatic                                    Left liver lobe                   US; CT, Hepatic arteriography   Solitary     6.0             Resection
  Mali et al\[[@B10]\]         1986       M/63          Hepatomegaly                                    Right liver lobe subcapsule       US; CT                          Solitary     15.0            No treatment
  Rubin et al\[[@B11]\]        1984       F/56          Abdominal pain, RUQ tenderness                  Right post segment subcapsule     CT, Hepatic arteriography       Solitary     8.0             Resection
  AFIP case\[[@B12]\]          1976       F/53          NA                                              Left liver lobe                   NA                              Solitary     2.0             NA

AFIP: Armed Forces Institute of Pathology; M: Male; F: Female; NA: Not available; US: Ultrasound; CT: Computed tomography; MRI: Magnetic resonance imaging; CEUS: Contrast-enhanced ultrasound.

###### 

Summary of clinical data from all 11 cases of hepatic myelolipoma

                                                  ***n* (%) or mean ± SD (range)**
  ----------------------------------------------- ----------------------------------
  Age (yr) (*n* = 11)                             
  Mean                                            51.45 ± 16.74 (25-76)
  Sex (male/female), (male %) (*n* = 11)          5/6 (45.45)
  Symptoms (*n* = 10)                             
  Asymptomatic                                    4 (40.00)
  Symptomatic (*n* = 10)                          
  Abdominal pain                                  3 (30.00)
  Symptoms related to a urinary tract infection   1 (10.00)
  Malaise                                         1 (10.00)
  Anorexia                                        1 (10.00)
  Fever                                           1 (10.00)
  Hepatomegaly                                    1 (10.00)
  Location (*n* = 11)                             
  Right liver lobe                                9 (81.82)
  Left liver lobe                                 2 (18.18)
  Mean size (cm) (*n* = 11)                       6.69 ± 4.71 (1.4-15)
  Operation (*n* = 11)                            
  Resection                                       7 (63.64)
  No resection                                    1 (9.09)
  Not available                                   3 (27.27)

The etiology of hepatic myelolipoma remains uncertain. An ectopic adrenal gland is one hypothesis\[[@B8]\]. Most myelolipomas are reported in the adrenal gland. Anatomically, the right adrenal gland is adjacent to the right lobe of the liver, and an ectopic adrenal gland rarely appears in liver parenchyma\[[@B8]\]. Except for two cases, hepatic myelolipomas were found in the subcapsular region of the right liver lobe, including in our case. Emboli from bone marrow represent another hypothesis for the histogenesis of these lesions\[[@B4]\]. Although the gross appearance of a myelolipoma suggests a neoplastic origin, light and electron microscopy studies have revealed the polyclonal character of the hematopoietic cells\[[@B26]\]. The definitive stimulus that causes the hematopoietic and fat cells to proliferate remains enigmatic. Several studies have suggested that tissue necrosis is the basic stimulus\[[@B6],[@B26]\]. For example, Van Hoe et al\[[@B6]\] speculated that the presence of foci of tumor necrosis may be associated with the development of a myelolipoma. Malignant tumors, hypertension, obesity, burns, and endocrinopathies have also been reported to be associated with the development of a myelolipoma\[[@B26]\].

The preoperative diagnosis of a hepatic myelolipoma is challenging. The appearance of myelolipomas on US, CT, and MRI images depends on the proportions of fat relative to myelogenous components\[[@B6]\]. US imaging reveals the myelolipoma to be a hyperechoic lesion\[[@B5],[@B8]\]. Unenhanced CT images usually show that the tumor is well-encapsulated and has low-density areas varying from -69 to 28 HU as a result of intratumoral hemorrhage and varying proportions of fat and bone marrow elements\[[@B6],[@B9]\]. On enhanced CT images, the tumor appears moderately enhanced. The area of low density remains hypoattenuated\[[@B27]\]. On T1-weighted MR images, the mass usually appears well marginated with a capsule, shows heterogeneous hyperintensity and contains necrosis. Hepatic arteriography reveals a hypervascular mass with an avascular zone\[[@B8],[@B11]\]. On T2-weighted images, the mass shows heterogeneous low-signal intensity. After the administration of a gadolinium bolus, the lesion may show delayed heterogeneous enhancement\[[@B5],[@B28]\]. Hepatic myelolipoma should be distinguished from other hepatic lesions that cause lipomatous masses, including lipomas, angiomyolipomas, metastatic dermoid tumors, Langerhans cell histiocytosis, and focal fatty infiltration\[[@B29]\]. Areas of fatty degeneration can also be observed occasionally in HCCs and hepatic adenomas\[[@B30]\].

Although myelolipomas are benign, these types of tumor can be symptomatic and may increase in size. Thus, surgical intervention is warranted when the tumor is symptomatic or difficult to diagnose. In the present study, the hepatic myelolipoma could not be preoperatively diagnosed precisely. Furthermore, two HCCs were synchronously found in the left liver lobe. HCC is the sixth most common malignancy worldwide and has the third highest mortality among cancer patients\[[@B31],[@B32]\], for whom surgical resection is the most common and effective therapeutic method. Accordingly, we performed a right hepatectomy and a left hepatic lobectomy to completely resect the hepatic myelolipoma and HCCs. Because the gallbladder was close to the tumor, a cholecystectomy was also performed. Histopathologic and immunohistochemical analyses of the surgical specimen confirmed the diagnosis of hepatic myelolipoma and HCCs. Microscopically, the hepatic myelolipoma was composed of fat cells and hematopoietic cells, including mature and developing myeloid, erythroid, and megakaryocytic cells. Marrow-like areas were also clearly observed.

In conclusion, hepatic myelolipoma is extremely rare. To our knowledge, only 10 cases have been reported in the English-language medical literature. In one of these cases, the myelolipoma was found within a HCC. In the present study, we report the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient, who received a right hepatectomy, a left hepatic lobectomy, and a cholecystectomy.

COMMENTS
========

Case characteristics
--------------------

A 26-year-old female was admitted to our hospital because of a 4-d history of upper abdominal pain.

Clinical diagnosis
------------------

Abdomen was soft, lax, and non-distended, with no palpable mass.

Differential diagnosis
----------------------

Differential diagnoses included lipomas, angiomyolipomas, metastatic dermoid tumor, and Langerhans cell histiocytosis.

Laboratory diagnosis
--------------------

Abnormal laboratory results: alpha fetoprotein (AFP), 7529.2 ng/mL (normal, 20); carbohydrate antigen 125, 99.4 U/mL (normal, 0-35); serum creatinine, 42 μmol/L (normal, 45-84); serum sodium 131 mmol/L (normal, 136-145); glutamyl transpeptidase, 103 U/L (normal, 7-32); fibrinogen, 4.45 g/L (normal, 2.00-4.00); and D-2-dimer, 9611 μg/L (normal, 0-700).

Imaging diagnosis
-----------------

The unenhanced computed tomography (CT) images showed a well-defined low-density mass with adipose components in the right liver lobe, 4.2 cm × 4.1 cm in size. Two inhomogeneous low-density masses were found in the left liver lobe, 8.6 cm × 7.7 cm and 2.6 cm × 2.6 cm in size. In the contrast-enhanced CT images, the masses in both the right and left liver lobes were heterogeneously enhanced. Based on the results of the imaging examination, the mass in the right liver lobe was preliminarily considered to be a hamartoma, and the two masses in the left liver lobe were preliminarily considered to be hepatocellular carcinoma (HCC).

Pathological diagnosis
----------------------

Macroscopically, the two masses in the left liver lobe were solid and were 9.5 cm × 6.5 cm × 5 cm and 3.2 cm × 2.0 cm in size, respectively. The mass in the right liver lobe had a capsule, was solid and 5.0 cm × 4.0 cm in size. Microscopically, the tumor in the right liver lobe consisted of adipose tissue and hematopoietic elements containing erythroid tissue, megakaryocytes and myeloid colonies, which was consistent with a myelolipoma. The tumor cells in the left liver lobe were in a funicular arrangement and had invasive growth with significant atypia, which was compatible with malignant hepatic cancer. Immunohistochemical investigation showed that hepatocyte and CD34 proteins were positive in the tumors of the left liver lobe, while AFP, GPC-3, HMB45, Melan-A, and SMA were negative. Finally, the tumor in the right liver lobe was diagnosed as a hepatic myelolipoma, and the tumors in the left liver lobe were diagnosed as HCCs.

Treatment
---------

The authors performed a right hepatectomy, a left hepatic lobectomy and a cholecystectomy.

Related reports
---------------

Hepatic myelolipoma is extremely rare. To date, only 10 cases have been reported in the English-language medical literature.

Experiences and lessons
-----------------------

In the present study, the authors present the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient. Preoperative diagnosis of hepatic myelolipoma is challenging. Surgery is the most effective treatment for the tumor.

Peer-review
-----------

This study highlights the diagnosis and treatment of the first case of the synchronous occurrence of hepatic myelolipoma and HCCs in different liver sections of one patient. This study also presents a literature review to deepen our understanding of hepatic myelolipoma. The information included is worthwhile to the reader.
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